This inventor holds 3 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Bayer Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, The Broad Institute, Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 12,268 
2 out of 387 
1 out of 486 
Years Active: 2021-2025
Title: The Innovative Contributions of Till Freudenberger
Introduction
Till Freudenberger is a notable inventor based in Velbert, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating cardiovascular diseases. With a total of 3 patents to his name, Freudenberger's work reflects a commitment to advancing medical science.
Latest Patents
Freudenberger's latest patents include innovative compounds that serve as potential treatments for various cardiovascular conditions. One of his notable patents is for "Substituted hydantoinamides as ADAMTS7 antagonists." This application focuses on substituted hydantoinamides of a specific formula, which are designed to act as antagonists for ADAMTS7. The patent outlines processes for their preparation and their use in treating diseases such as atherosclerosis and coronary artery disease.
Another significant patent is for "7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof." This application discusses novel compounds that can be utilized for the treatment and prevention of cardiovascular and renal disorders. The innovative nature of these compounds highlights Freudenberger's dedication to addressing critical health issues.
Career Highlights
Throughout his career, Till Freudenberger has worked with prominent companies in the pharmaceutical industry. He has been associated with Bayer Aktiengesellschaft and Bayer Pharma Aktiengesellschaft, where he contributed to various research and development projects. His experience in these organizations has played a crucial role in shaping his expertise in medicinal chemistry.
Collaborations
Freudenberger has collaborated with several professionals in his field, including Henrik Teller and Alexandros Vakalopoulos. These collaborations have likely enriched his research and contributed to the successful development of his patented inventions.
Conclusion
Till Freudenberger's innovative work in medicinal chemistry, particularly in the realm of cardiovascular treatments, showcases his significant contributions to the field. His patents reflect a deep understanding of complex medical challenges and a commitment to finding effective solutions. Freudenberger's career continues to inspire future innovations in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile